EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study

Adrienne Y L Chan, Le Gao, Louise M Howard, Emily Simonoff, Dave Coghill, Patrick Ip, Wallis C Y Lau, Katja Taxis, Ian C K Wong, Kenneth K C Man

Psychotherapy and Psychosomatics · 2023

DOI: 10.1159/000529141 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Psychotherapy and Psychosomatics, 2023. Verfasst von Adrienne Y L Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Premature Birth, Autism Spectrum Disorder, Prenatal Exposure Delayed Effects, Attention Deficit Disorder with Hyperactivity. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The use of benzodiazepines and/or z-drugs in women of childbearing age has increased.

Objective

The aim of the study was to evaluate whether gestational benzodiazepine and/or z-drug exposure is associated with adverse birth and neurodevelopmental outcomes.

Methods

A population-based cohort including mother-child pairs from 2001 to 2018 in Hong Kong was analysed to compare gestationally exposed and nonexposed children on the risk of preterm birth, small for gestational age, autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD) through logistic/Cox proportional hazards regression with a 95% confidence interval (CI). Sibling-matched analyses and negative control analyses were applied.

Results

When comparing gestationally exposed with gestationally nonexposed children, the weighted odds ratio (wOR) was 1.10 (95% CI = 0.97–1.25) for preterm birth and 1.03 (95% CI = 0.76–1.39) for small for gestational age, while the weighted hazard ratio (wHR) was 1.40 (95% CI = 1.13–1.73) for ASD and 1.15 (95% CI = 0.94–1.40) for ADHD. Sibling-matched analyses showed no association between gestationally exposed children and their gestationally nonexposed siblings for all outcomes (preterm birth: wOR = 0.84, 95% CI = 0.66–1.06; small for gestational age: wOR = 1.02, 95% CI = 0.50–2.09; ASD: wHR = 1.10, 95% CI = 0.70–1.72; ADHD: wHR = 1.04, 95% CI = 0.57–1.90). Similarly, no significant differences were observed when comparing children whose mothers took benzodiazepines and/or z-drugs during pregnancy to children whose mothers took benzodiazepines and/or z-drugs before but not during pregnancy for all outcomes.

Conclusions

The findings do not support a causal relationship between gestational benzodiazepines and/or z-drugs exposure and preterm birth, small for gestational age, ASD, or ADHD. Clinicians and pregnant women should carefully balance the known risks of benzodiazepines and/or z-drugs use against those of untreated anxiety and sleep problems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthAutism Spectrum DisorderPrenatal Exposure Delayed EffectsAttention Deficit Disorder with HyperactivityHumansInfant, NewbornPregnancyFemaleBenzodiazepinesCohort Studies

Stichwörter der Autor:innen

Attention deficit hyperactivity disorderAutism spectrum disorderBenzodiazepinesMental healthPregnancyPreterm birthSmall for gestational ageZ-drugs

Substanzen

Benzodiazepines

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong, China.
  • Laboratory of Data Discovery for Health, Hong Kong Science Park, Hong Kong, Hong Kong, China.
  • Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands.
  • Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
  • Section of Women's Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Zitieren

APA

Chan, A. Y. L., Gao, L., Howard, L. M., Simonoff, E., Coghill, D., Ip, P., Lau, W. C. Y., Taxis, K., Wong, I. C. K., & Man, K. K. C. (2023). Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000529141

Vancouver

Chan AYL, Gao L, Howard LM, Simonoff E, Coghill D, Ip P, et al. Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study. Psychotherapy and Psychosomatics. 2023. doi:10.1159/000529141

BibTeX
@article{Chan2023,
  author = {Chan, Adrienne Y L and Gao, Le and Howard, Louise M and Simonoff, Emily and Coghill, Dave and Ip, Patrick and Lau, Wallis C Y and Taxis, Katja and Wong, Ian C K and Man, Kenneth K C},
  title = {Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study},
  journal = {Psychotherapy and Psychosomatics},
  year = {2023},
  doi = {10.1159/000529141}
}
Kostenlos starten →